Swarnajit Dutta¹, Aliviya Das² and Arghya Bhattacharya³*

¹Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology and Allied Health sciences, Uluberia, Howrah, West Bengal, India
²Department of Pharmaceutical Chemistry, Calcutta Institute of Pharmaceutical Technology and Allied Health sciences, Uluberia, Howrah, West Bengal, India
³Assistant Professor, Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology and Allied Health sciences, Uluberia, Howrah, West Bengal, India

*Corresponding Author: Arghya Bhattacharya, Assistant Professor, Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology and Allied Health sciences, Uluberia, Howrah, West Bengal, India.

Received: December 22, 2021 Published: January 31, 2022

Coronavirus, presently coined as the 2019 novel coronavirus, appeared from Wuhan and give rise to a challenging outburst in many cities in China and extended internationally, including Thailand, United States, Japan and India. The disease is formally termed as Coronavirus Disease-2019. It is also coined as Severe Pneumonia with Novel Pathogens by the Taiwan CDC and is a remarkable transmissible disease of the fifth category. COVID-19 is inherently a zoonotic disease with low to moderate (estimated 2%-5%) mortality rate [1].

References

1. Jayaweera M and Perera H. “Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy”. Environmental Research 188 (2020): 340-415.
2. Fathizadeh H and Afshar S. “SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: a review”. International Journal of Biological Macromolecules188 (2021): 740-750.
3. Tyrrell DA and Bynoe ML. “Cultivation of viruses from a high proportion of patients with colds”. Lancet 1 (1966): 76-77.
4. Chakraborty C Sharma AR. “SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options”. European Review for Medical and Pharmacological Sciences 24 (2020): 4016-4026.
5. Zhou P and Lou XY. “A pneumonia outbreak associated with a new coronavirus of probable bat origin”. Nature579 (2020): 270-273.
6. Bulilete O and Lorente P. “Rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care”. Journal of Infection 82 (2021): 391-398.
7. Guglielmi G. “Rapid coronavirus tests: a guide for the perplexed”. Nature590 (2021): 202-205.
8. Baral PK and Yin J. “Treatment and prevention strategies for the COVID 19 pandemic: a review of immunotherapeutic approaches for neutralizing SARS-CoV-2”. International Journal of Biological Macromolecules186 (2021): 490-500.
9. Kaur M and Sharma A. “SARS-CoV-2: insights into its structural intricacies and functional aspects for drug and vaccine development”. International Journal of Biological Macromolecules179 (2021): 45-60.

Citation

Citation: Arghya Bhattacharya., et al. “Modern Approaches for Diagnosis of COVID 19: A REVIEW". Acta Scientific Pharmacology 3.2 (2022): 18-19.

Copyright

Copyright: © 2022 Arghya Bhattacharya., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.